While growing financial investment in “women’s health” has been celebrated by many as a victory for women and a sign of progress within the healthcare system, we challenge this idea in our new Lancet perspective “Women’s Health, Inc.”

Our new study evaluated the prevalence and performance of private equity-owned fertility clinics in the United States. This study is the first to quantify the extent to which private equity is acquiring swaths of the fertility industry.

The Harvard GenderSci is hiring an undergraduate research assistant for an exciting new project evaluating the rise of private equity in obstetrics/gynecology/fertility within the United States.